Join the Oncology Voice Network. Join for Free
It Can be Lonely in the Life of an MSL
Medical Science Liaison MSL mentorship KOL engagement professional development work-life balance

It Can be Lonely in the Life of an MSL


Share This Article


Summary

In this episode, Tom Caravela welcomes special guest Trish Gorecki to share her insights and experiences as a Medical Science Liaison (MSL). The conversation delves into overcoming challenges and frustrations in the MSL role, emphasizing the importance of mentorship and networking. Trish discusses coping strategies for isolation, handling setbacks, and improving Key Opinion Leader (KOL) engagement. The episode provides a comprehensive look at burnout, work-life balance, and effective time management, especially during travel. Trish highlights essential resources and tools for MSLs, stressing the significance of continuous personal and professional development. The episode concludes with final advice for both current and aspiring MSLs.

Key Points

  • Building and maintaining strong internal and external networks is crucial for overcoming the challenges and isolation often experienced by MSLs in the field.
  • Persistence and strategic relationship-building are key to gaining access to KOLs, especially in a competitive and evolving market landscape.
  • Taking personal responsibility for professional development through available resources, mentorship, and continuous learning can significantly enhance the effectiveness and satisfaction of MSLs.

Click for Source
Medical Science Liaison, MSL mentorship, KOL engagement, professional development, work-life balance

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
The Oncology Data Network (ODN): Methodology, Challenges, and Achievements
OVN Avatar Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

Article
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
OVN Avatar Alyson Haslam, PhD; Vinay Prasad, MD, MPH

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Article
Loose Regulatory Standards Portend a New Era of Imprecision Oncology
OVN Avatar Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Article
Expert perspectives live from ASCO® 2025
Partner Avatar iNIZIO

Expert perspectives live from ASCO® 2025

Explore OVN